A transformative advance in nuclear medicine imaging has emerged with the development of a novel PET radiotracer capable of detecting both deep vein thrombosis and pulmonary embolism in a single whole-body scan. Presented at the 2026 Society of Nuclear Medicine and Molecular Imaging Annual Meeting, this breakthrough technology addresses a critical diagnostic challenge by eliminating the need for multiple separate imaging procedures.
Traditional diagnostic protocols require patients to undergo duplex ultrasound for leg evaluation followed by computed tomography pulmonary angiography for suspected lung involvement—a process that delays treatment decisions in time-sensitive cases. The new PET approach provides comprehensive visualization of blood clots throughout the venous system simultaneously, potentially reducing diagnostic time and enabling faster clinical decision-making.
The achievement has garnered significant recognition within the medical imaging community, with the research selected as the 2026 SNMMI Henry N. Wagner, Jr., Image of the Year award. Read the full article on GMJ Newsroom.
Was this article helpful?
